drugset / Trial / NCT00512980

PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma

NCT00512980

Phase 2 Terminated University of Cologne
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized phase II study of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with intermediate stage Hodgkin's lymphoma

Timeline

Start
2008-08
Primary completion
2013-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxorubicin Other / unclassified
Comparator Gemcitabine Small molecule
Comparator Prednisone Other / unclassified
Comparator Vinblastine Small molecule

Indications